Refine your search

Search

    Filter by

    Location
      Age (years)
      Sex

      Show filters

      Join PfizerLink — a clinical research registry

      Get notified about clinical trials that may be right for you — now and over time. Share some information about your health and medical areas of interest. We’ll reach out if a Pfizer clinical trial may be a fit.

      Sickle Cell Disease clinical trial

      The DREAM study is exploring whether a study medicine can reduce symptoms and improve the overall health of people with Sickle Cell Disease.

      25 trials found for Breast cancer, Breast Neoplasm

      All(25)
      Recruiting(21)
      Not yet recruiting(4)
      3 trials recruiting
      Pfizer Breast Cancer Clinical Trials

      Pfizer has several study medicines in development that may have the potential to help people with various types of breast cancer.

      Recruiting
      NCT06206837
      A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.

      Breast Cancer

      Male or Female
      18+ years
      22study location(s)
      Recruiting
      NCT05654623
      A Study to Learn About a New Medicine Called ARV-471 (PF-07850327) in People Who Have Advanced Metastatic Breast Cancer.

      Advanced Breast Cancer

      Male or Female
      18+ years
      560study location(s)
      Recruiting
      NCT04389632
      A Study of SGN-B6A in Advanced Solid Tumors

      Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, HER2 Negative Breast Neoplasms, Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Ovarian Neoplasms, Cutaneous

      Male or Female
      18+ years
      23study location(s)
      Recruiting
      NCT06157892
      A Study of Disitamab Vedotin Alone or With Other Anticancer Drugs in Solid Tumors

      Breast Neoplasms, Gastroesophageal Junction Adenocarcinoma, HER2 Low Breast Neoplasms, HER2 Positive Breast Neoplasms, Stomach Neoplasms, Triple Negative Breast Neoplasms

      Male or Female
      18+ years
      13study location(s)
      Recruiting
      NCT05132582
      A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast Cancer

      HER2 Positive Breast Cancer

      Male or Female
      18+ years
      258study location(s)
      Recruiting
      NCT03975647
      A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast Cancer

      HER2-positive Breast Cancer

      Male or Female
      18+ years
      25study location(s)
      Recruiting
      NCT05194072
      A Study of SGN-B7H4V in Advanced Solid Tumors

      Ovarian Neoplasms, Peritoneal Neoplasms, Fallopian Tube Neoplasms, Triple Negative Breast Neoplasms, HER2 Negative Breast Neoplasms, Hormone Receptor Positive Breast Neoplasms, Endometrial Neoplasms, Carcinoma, Non-Small-Cell Lung,

      Male or Female
      18+ years
      19study location(s)
      Recruiting
      NCT04767594
      First-line Palbociclib and Endocrine Therapy for Patients With HR+/HER2- Advanced Breast Cancer in the Real-world Setting.

      Breast Neoplasms

      Male or Female
      18+ years
      189study location(s)
      Recruiting
      NCT04654208
      Swedish Ibrance Registries Insights (SIRI)

      Malignant Neoplasm of Breast

      Male or Female
      18 - 99 years
      1study location(s)
      Recruiting
      NCT05548127
      TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer (Sub-Study A)

      Breast Cancer

      Male or Female
      18+ years
      43study location(s)

      Saved trials

      Saved trials

      You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

      All(25)
      Recruiting(21)
      Not yet recruiting(4)

      Contact us

      For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.